Romvimza 30 MG capsule UU 8S
Ended Awarded
- Contract number
- SPE2DB25FXN39
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,734
Award facts
- Contract value 100% obligated
- $17,734.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,734.15 to AmerisourceBergen Drug Corp for Romvimza 30 mg capsules (UU 8s) on September 26, 2025, with an ultimate completion date of October 20, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and is being performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across the military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Romvimza capsules continues AmerisourceBergen's established role as a primary supplier under DLA's pharmaceutical procurement framework, supporting the agency's mission to provide comprehensive medical supply chain support to Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FXN39?
SPE2DB25FXN39 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FXN39 worth?
The government has obligated $17,734 on SPE2DB25FXN39.
Is contract SPE2DB25FXN39 an order under another contract?
Yes. SPE2DB25FXN39 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXN39 competed?
The extent of competition for SPE2DB25FXN39 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award